MedTrace Logo

A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)

NCT00694369 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 588

Last updated 2022-02-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the pain relieving effect of different doses of MK0663 with placebo and other pain relievers/analgesics in patients with postoperative dental pain. Pain intensity and relief will be measured by the total pain relief score (TOPAR) and patient evaluation.

Conditions

  • Postoperative Dental Pain

Interventions

DRUG

Comparator: etoricoxib

etoricoxib 90 mg; 120 mg (once daily) over three days.

DRUG

Comparator: ibuprofen

ibuprofen 2400 mg (600 mg Q6h) over three Days

DRUG

Comparator: acetaminophen + codeine

acetaminophen 2400 mg/codeine 240 mg (600/60 mg Q6h) over three Days

DRUG

Comparator: placebo

matching placebo over three Days

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-12-31
Completion
2009-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00694369 on ClinicalTrials.gov